Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 06, 2020

SELL
$264.77 - $305.71 $693,697 - $800,960
-2,620 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $338,844 - $448,740
1,310 Added 100.0%
2,620 $701,000
Q2 2018

Sep 07, 2018

BUY
$257.52 - $306.91 $337,351 - $402,052
1,310 New
1,310 $443,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sp Asset Management Portfolio

Follow Sp Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sp Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Sp Asset Management with notifications on news.